Navigation Links
ViroPharma to Release 2010 Fourth Quarter and Full Year Financial Results on February 24, 2011
Date:2/10/2011

products, please download the package inserts at http://www.viropharma.com/Products.aspx).  ViroPharma currently focuses its drug development activities in diseases including C1 esterase inhibitor deficiency and C. difficile.

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's web site, www.viropharma.com. The company encourages investors to consult these sections for more information on ViroPharma and our business.


'/>"/>
SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ViroPharma to Participate in Several Upcoming Healthcare Investor Conferences
2. ViroPharma Receives Complete Response Letter for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Supplement
3. ViroPharma to Release 2010 Third Quarter Financial Results on October 27, 2010
4. ViroPharma to Present at the Jefferies 2010 Global Healthcare Conference
5. ViroPharma Announces Presentation of Data from Non-Toxigenic Clostridium difficile (VP20621) Phase 1 Study
6. ViroPharma To Participate in Two September Healthcare Investor Conferences
7. ViroPharma Announces Publication of Cinryze™ (C1 Esterase Inhibitor [Human]) Phase 3 Trial Results in Hereditary Angioedema (HAE) in the New England Journal of Medicine
8. ViroPharma Files Prior Approval Supplement (PAS) for Cinryze™ (C1 Esterase Inhibitor [Human]) Industrial Scale Manufacturing
9. ViroPharma to Participate in Two June Healthcare Investor Conferences
10. ViroPharma To Host Investor Day
11. ViroPharma to Participate in the Cowen and Company 30th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)...  An international roster of experts on malignant pleural ... Santa Monica, Calif. , to discuss their ... a rare form of cancer that results from exposure ... of the chest. Hosted by UCLA and ... Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural ...
(Date:5/24/2013)... May 24, 2013 In accordance with Rule 17.1 ... 14e-1 of the United States Exchange Act, Echo Pharma Acquisition ... for Elan Corporation (NYSE: ELN). Background ... made an offer for the entire of the issued and ... (the "Original Offer").  On 20 May 2013, ...
(Date:5/23/2013)... 3SBio Inc. (NASDAQ: SSRX ... China -based biotechnology company focused on ... today that, at an extraordinary general meeting held ... favor of the proposal to authorize and approve ... dated February 8, 2013, among Decade Sunshine Limited, ...
Breaking Medicine Technology:International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 2International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 93SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3
(Date:5/24/2013)... 24, 2013 E-Dentists.com has announced the ... with JD Media Surge, a leading medical Internet marketing ... SEO analysis service will focus on providing dentists the ... engines for their competitive keywords. The dental SEO analysis ... recommendations based on what their competitors are doing right. ...
(Date:5/24/2013)... 24, 2013 Started in 1982, AMTC’s SHINE ... Orlando. 2013 marks AMTC’s 31st anniversary. SHINE is a ministry ... supermodel Millie Lewis and her daughter, Carey Lewis Arban. , ... casting directors, and music professionals including the New York Film ... Media. They are kings of Hollywood and Christian casting directors. ...
(Date:5/24/2013)... Utah (PRWEB) May 24, 2013 Amirsys ... with exciting new enhancements for instructors and students. Instructors ... more focused through personalize learning plan templates, targeted reading ... release provides 500 new assessment questions, 5,000 searchable anatomy ... notes. , AnatomyOne 2.0 is the first ...
(Date:5/24/2013)... Dwell Media LLC announces the ... Vice President of Digital for Dwell Media. At Yahoo, ... large portion of Yahoo's global media business. At Dwell, ... fully-integrated commerce unit to launch in 2014. Huff brings ... for leading firms in Silicon Valley. Dwell, which has ...
(Date:5/24/2013)... minority parents have more realistic views about their ... vaccinating their daughters against the cervical cancer-causing human ... Conversely, white, middle-class parents are more likely to ... researchers from the Boston University School of Medicine. ... cancer each year, many of which can be ...
Breaking Medicine News(10 mins):Health News:Dental SEO Analysis Launched by E-Dentists.com in Partnership with JD Media Surge 2Health News:AMTC’s Summer SHINE Event Coming to Orlando’s Luxurious Gaylord Palms July 2-7, 2013 2Health News:Amirsys AnatomyOne 2.0 Delivers Personalized Learning Plans 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:Low-Income, Minority Parents More Open to HPV Vaccine for Girls, Study Says 2
... , WEDNESDAY, Feb. 23 (HealthDay News) -- The main ... regain their ability to taste and enjoy food, according to ... could potentially lead to treatments to help some cancer patients ... to smell and taste food, which can cause them to ...
... a factory or at a rock concert, noise-induced hearing loss ... Researchers at Washington University School of Medicine in St. Louis ... in mice when given before they are exposed to loud ... hearing loss after noise exposure. While both drugs are ...
... - Understanding the genetics of bipolar disorder could lead ... with this disorder has been challenging. A ... brain protein called Piccolo in the risk for inheriting ... is a member of a protein family that includes ...
... percent of the world,s population is currently infected by hepatitis ... cirrhosis and liver cancer, and it,s the most frequent cause ... we have no traditional vaccine, but researchers at the University ... a vaccine, which provides future hope for medical protection from ...
... , WEDNESDAY, Feb. 23 (HealthDay News) -- People,s ... to stress, according to a new study. To reach ... make a speech in a laboratory in front of a ... responses were monitored during the speech, and they were later ...
... after having early-stage breast cancer, but they are at ... a new cancer, in either breast. Annual screening (a.k.a. ... but only scant evidence on screening outcomes supported this ... the American Medical Association , the most comprehensive relevant ...
Cached Medicine News:Health News:Pot Ingredient May Restore Appetite After Chemo 2Health News:2 drugs protect hearing better than 1 2Health News:A new clue to the genetics of bipolar disorder: Piccolo 2Health News:New vaccine technology protects mice from hepatitis C virus 2Health News:New vaccine technology protects mice from hepatitis C virus 3Health News:New vaccine technology protects mice from hepatitis C virus 4Health News:Screening mammograms catch second breast cancers early 2